0000874015-20-000090.txt : 20200706 0000874015-20-000090.hdr.sgml : 20200706 20200706172511 ACCESSION NUMBER: 0000874015-20-000090 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200701 FILED AS OF DATE: 20200706 DATE AS OF CHANGE: 20200706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERTHELSEN SPENCER R CENTRAL INDEX KEY: 0001181548 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 201014376 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-07-01 0000874015 IONIS PHARMACEUTICALS INC IONS 0001181548 BERTHELSEN SPENCER R C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 1 0 0 0 Common Stock 2020-07-01 2020-07-01 4 M 0 666 0 A 97649 D Common Stock 2020-07-01 2020-07-01 4 M 0 1778 0 A 99427 D Common Stock 2020-07-02 2020-07-02 4 M 0 889 0 A 100316 D Common Stock 2020-07-06 2020-07-06 4 M 0 667 0 A 100983 D Common Stock 70 I By daughter Restricted Stock Units 2020-07-01 2020-07-01 4 M 0 666 0 D Common Stock 666 0 D Restricted Stock Units 2020-07-01 2020-07-01 4 M 0 1778 0 D Common Stock 1778 5332 D Restricted Stock Units 2020-07-02 2020-07-02 4 M 0 889 0 D Common Stock 889 1777 D Restricted Stock Units 2020-07-06 2020-07-06 4 M 0 667 0 D Common Stock 667 666 D Restricted Stock Units 0 2020-07-01 2020-07-01 4 A 0 5333 0 A Common Stock 5333 5333 D Director Stock Option (right to buy) 60.20 2020-07-01 2020-07-01 4 A 0 12000 0 A 2021-07-01 2030-06-30 Common Stock 12000 12000 D Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. The reporting person disclaims beneficial ownership of all securities held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. These Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Grant of July 1, 2020 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2020. Grant of July 1, 2020 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2020. /s/Patrick R. O'Neil, attorney-in-fact 2020-07-06